Event Recap: The Role of Medicines in Value-Based Payment and Health Care Delivery
The forum was the third and final event in an educational series, hosted by the Bipartisan Policy Center, to inform the national conversation on affordable medicines. The purpose of these forums was to seek an understanding of how private sector decisions and public sector policies impact the prices of drugs and their costs to the health care system. They highlighted what is known about the present system and explored the full range of viewpoints on this issue.
The final forum addressed how pharmaceuticals fit into a value-based payment system.
Join the discussion on Twitter: @BPC_Bipartisan #BPClive
Opening remarks by:
Co-Founder, Bipartisan Policy Center
Former Senate Majority Leader
Mark McClellan, M.D., Ph.D
Director, Duke-Robert J. Margolis, MD, Center for Health Policy, Duke University
View presentation slides
Panel discussion with:
Alex M. Azar II
President, Lilly USA, LLC
Former Deputy Secretary, Health and Human Services
Executive Vice President, Medical Affairs, CareFirst BlueCross BlueShield
Eleanor M. Perfetto, PhD, MS
Senior Vice President, Strategic Initiatives, National Health Council
Lowell E. Schnipper, M.D.
Chair, American Society of Clinical Oncology Value in Cancer Care Task Force
Theodore and Evelyn Berenson Professor of Medicine, Harvard Medical School